Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Payables (2020 - 2025)

iSpecimen has reported Payables over the past 6 years, most recently at $5.4 million for Q4 2025.

  • For Q4 2025, Payables rose 27.76% year-over-year to $5.4 million; the TTM value through Dec 2025 reached $5.4 million, up 27.76%, while the annual FY2025 figure was $5.4 million, 27.76% up from the prior year.
  • Payables for Q4 2025 was $5.4 million at iSpecimen, up from $4.8 million in the prior quarter.
  • Over five years, Payables peaked at $5.5 million in Q2 2024 and troughed at $281494.0 in Q1 2022.
  • A 5-year average of $3.1 million and a median of $3.6 million in 2024 define the central range for Payables.
  • Biggest five-year swings in Payables: crashed 72.17% in 2022 and later skyrocketed 1182.28% in 2023.
  • Year by year, Payables stood at $832678.0 in 2021, then soared by 195.32% to $2.5 million in 2022, then skyrocketed by 59.63% to $3.9 million in 2023, then grew by 6.93% to $4.2 million in 2024, then increased by 27.76% to $5.4 million in 2025.
  • Business Quant data shows Payables for ISPC at $5.4 million in Q4 2025, $4.8 million in Q3 2025, and $4.3 million in Q2 2025.